MEDTRONIC MEXICO EUPHORA RX; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
|
Back to Search Results |
|
Catalog Number EUP3020X |
Device Problems
Burst Container or Vessel (1074); Detachment of Device or Device Component (2907)
|
Patient Problem
No Consequences Or Impact To Patient (2199)
|
Event Date 05/08/2020 |
Event Type
malfunction
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
During the procedure an attempt was made to use one euphora rx ptca balloon catheter to treat a mildly tortuous and mildly calcified lesion.The device was inspected with no issues noted.The lesion was pre dilated.Resistance was encountered when advancing the device.It was reported that the balloon burst during the second balloon inflation at 9-10 atm.It was stated that during first inflation the plaque was not completely pushed back against the vessel wall.Therefore, a second inflation was performed with the same balloon, and it burst.On examination of the balloon, it was observed that the burst caused a large portion of the balloon material to be ripped off from the catheter.No patient injury reported.
|
|
Manufacturer Narrative
|
Additional information: the lesion was located in the mid left anterior descending (lad) artery.Negative prep was performed.Excessive force was not used.The device was not moved or re-positioned while inflated.The detached portion was pulled out from the patient with the rest of the device.The same inflation device was used successfully with other devices.Correction: device code c63242 added medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Product analysis summary: a kink was evident on the distal shaft.There was no blood visible in the balloon.The balloon folds were open.There was a longitudinal tear on the balloon material from the distal cone to the mid-section of the balloon.The balloon material was lifted but still attached at the distal cone.The balloon material was jagged and uneven at the tear site.There was no lead in scratches distal or proximal to the tear site.There was no other damage evident to the remainder of the device.An image provided is of the distal section on a euphora device.The balloon material is torn from the distal cone to the mid-section of the balloon.The material is lifted at the tear site but appears to be still attached at the distal cone.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|